Kevin Schuyler - Net Worth and Insider Trading

Kevin Schuyler Net Worth

The estimated net worth of Kevin Schuyler is at least $27,854 dollars as of 2024-12-12. Kevin Schuyler is the Director of Forza X1 Inc and owns about 100,000 shares of Forza X1 Inc (FRZA) stock worth over $20,000. Kevin Schuyler is the Director of Adial Pharmaceuticals Inc and owns about 6,589 shares of Adial Pharmaceuticals Inc (ADIL) stock worth over $7,248. Kevin Schuyler is also the Director of Twin Vee PowerCats Co and owns about 1,363 shares of Twin Vee PowerCats Co (VEEE) stock worth over $607. Details can be seen in Kevin Schuyler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Schuyler has not made any transactions after 2024-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Kevin Schuyler

To

Kevin Schuyler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Schuyler owns 3 companies in total, including Adial Pharmaceuticals Inc (ADIL) , Twin Vee PowerCats Co (VEEE) , and Forza X1 Inc (FRZA) .

Click here to see the complete history of Kevin Schuyler’s form 4 insider trades.

Insider Ownership Summary of Kevin Schuyler

Ticker Comapny Transaction Date Type of Owner
ADIL Adial Pharmaceuticals Inc 2023-09-29 director
VEEE Twin Vee PowerCats Co 2022-12-22 director
FRZA Forza X1 Inc 2024-09-17 director

Kevin Schuyler Latest Holdings Summary

Kevin Schuyler currently owns a total of 3 stocks. Among these stocks, Kevin Schuyler owns 100,000 shares of Forza X1 Inc (FRZA) as of September 17, 2024, with a value of $20,000 and a weighting of 71.8%. Kevin Schuyler owns 6,589 shares of Adial Pharmaceuticals Inc (ADIL) as of September 29, 2023, with a value of $7,248 and a weighting of 26.02%. Kevin Schuyler also owns 1,363 shares of Twin Vee PowerCats Co (VEEE) as of December 22, 2022, with a value of $607 and a weighting of 2.18%.

Latest Holdings of Kevin Schuyler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FRZA Forza X1 Inc 2024-09-17 100,000 0.20 20,000
ADIL Adial Pharmaceuticals Inc 2023-09-29 6,589 1.10 7,248
VEEE Twin Vee PowerCats Co 2022-12-22 1,363 0.45 607

Holding Weightings of Kevin Schuyler


Kevin Schuyler Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Schuyler has made a total of 3 transactions in Forza X1 Inc (FRZA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Forza X1 Inc is the acquisition of 90,668 shares on September 17, 2024, which cost Kevin Schuyler around $27,200.

According to the SEC Form 4 filings, Kevin Schuyler has made a total of 1 transactions in Adial Pharmaceuticals Inc (ADIL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adial Pharmaceuticals Inc is the acquisition of 700 shares on September 29, 2023, which cost Kevin Schuyler around $1,918.

According to the SEC Form 4 filings, Kevin Schuyler has made a total of 1 transactions in Twin Vee PowerCats Co (VEEE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Twin Vee PowerCats Co is the acquisition of 1,363 shares on December 22, 2022, which cost Kevin Schuyler around $2,426.

Insider Trading History of Kevin Schuyler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Schuyler Trading Performance

GuruFocus tracks the stock performance after each of Kevin Schuyler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Schuyler is -9.2%. GuruFocus also compares Kevin Schuyler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Schuyler within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin Schuyler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin Schuyler

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.89 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.59 LIMIT LIMIT LIMIT LIMIT LIMIT

Kevin Schuyler Ownership Network

Ownership Network List of Kevin Schuyler

No Data

Ownership Network Relation of Kevin Schuyler

Insider Network Chart

Kevin Schuyler Owned Company Details

What does Adial Pharmaceuticals Inc do?

Who are the key executives at Adial Pharmaceuticals Inc?

Kevin Schuyler is the director of Adial Pharmaceuticals Inc. Other key executives at Adial Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Stilley William B. Iii , director & 10 percent owner Bankole A. Johnson , and COO and CFO Joseph Truluck .

Adial Pharmaceuticals Inc (ADIL) Insider Trades Summary

Over the past 18 months, Kevin Schuyler made 1 insider transaction in Adial Pharmaceuticals Inc (ADIL) with a net purchase of 700.

In summary, during the past 3 months, insiders sold 0 shares of Adial Pharmaceuticals Inc (ADIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adial Pharmaceuticals Inc (ADIL) were sold and 700 shares were bought by its insiders, resulting in a net purchase of 700 shares.

Adial Pharmaceuticals Inc (ADIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adial Pharmaceuticals Inc Insider Transactions

No Available Data

Kevin Schuyler Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Schuyler. You might contact Kevin Schuyler via mailing address: 1180 Seminole Trail, Suite 495, Charlottesville Va 22901.